Nakagawa et al., 2022 - Google Patents
Right ventricular dimension for heart failure with preserved ejection fraction involving right ventricular-vascular uncouplingNakagawa et al., 2022
View HTML- Document ID
- 8415546105990723707
- Author
- Nakagawa A
- Yasumura Y
- Yoshida C
- Okumura T
- Tateishi J
- Seo M
- Yano M
- Hayashi T
- Nakagawa Y
- Tamaki S
- Yamada T
- Sotomi Y
- Nakatani D
- Hikoso S
- Sakata Y
- Osaka CardioVascular Conference (OCVC)-Heart Failure Investigators
- et al.
- Publication year
- Publication venue
- CJC open
External Links
Snippet
Background Right ventricular (RV) to pulmonary artery (PA) uncoupling is known to be important for the prognosis of not only heart failure (HF) with reduced ejection fraction but also HF with preserved ejection fraction (HFpEF). We further investigated key factors in the …
- 206010007554 Cardiac failure 0 title abstract description 55
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/04—Detecting, measuring or recording bioelectric signals of the body of parts thereof
- A61B5/0402—Electrocardiography, i.e. ECG
- A61B5/0452—Detecting specific parameters of the electrocardiograph cycle
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Abraham et al. | Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium | |
| Task Force for the management of COVID-19 of the European Society of Cardiology Baigent Colin colin. baigent@ ndph. ox. ac. uk Windecker Stephan stephan. windecker@ insel. ch Andreini Daniele Arbelo Elena Barbato Emanuele Bartorelli Antonio L Baumbach Andreas Behr Elijah R Berti Sergio Bueno Héctor Capodanno Davide Cappato Riccardo Chieffo Alaide Collet Jean Philippe Cuisset Thomas de Simone Giovanni Delgado Victoria Dendale Paul Dudek Dariusz Edvardsen Thor Elvan Arif González-Juanatey José R Gori Mauro Grobbee Diederick Guzik Tomasz J Halvorsen Sigrun Haude Michael Heidbuchel Hein Hindricks Gerhard Ibanez Borja Karam Nicole Katus Hugo Klok Fredrikus A Konstantinides Stavros V Landmesser Ulf Leclercq Christophe Leonardi Sergio Lettino Maddalena Marenzi Giancarlo Mauri Josepa Metra Marco Morici Nuccia Mueller Christian Petronio Anna Sonia Polovina Marija M Potpara Tatjana Praz Fabien Prendergast Bernard Prescott Eva Price Susanna Pruszczyk Piotr Rodríguez-Leor Oriol Roffi Marco Romaguera Rafael Rosenkranz Stephan Sarkozy Andrea Scherrenberg Martijn Seferovic Petar Senni Michele Spera Francesco R Stefanini Giulio Thiele Holger Tomasoni Daniela Torracca Luccia Touyz Rhian M Wilde Arthur A Williams Bryan | ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up | |
| Beghini et al. | 2024 update in heart failure | |
| Aimo et al. | Imaging, biomarker, and clinical predictors of cardiac remodeling in heart failure with reduced ejection fraction | |
| Shah et al. | Echocardiographic features of patients with heart failure and preserved left ventricular ejection fraction | |
| Bosch et al. | Right ventricular dysfunction in left‐sided heart failure with preserved versus reduced ejection fraction | |
| Gorter et al. | Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease | |
| Sato et al. | Low T3 syndrome is associated with high mortality in hospitalized patients with heart failure | |
| Cohen et al. | Effects of empagliflozin treatment on cardiac function and structure in patients with type 2 diabetes: a cardiac magnetic resonance study | |
| Hwang et al. | Implications of coronary artery disease in heart failure with preserved ejection fraction | |
| Thibodeau et al. | Characterization of a novel symptom of advanced heart failure: bendopnea | |
| Machino-Ohtsuka et al. | Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction | |
| Mueller et al. | B-type natriuretic peptide for acute dyspnea in patients with kidney disease: insights from a randomized comparison | |
| Inciardi et al. | Right ventricular function and pulmonary coupling in patients with heart failure and preserved ejection fraction | |
| Hahn et al. | Tricuspid regurgitation in patients with heart failure and preserved ejection fraction: JACC state-of-the-art review | |
| Harada et al. | Diagnostic value of reduced left atrial compliance during ergometry exercise in heart failure with preserved ejection fraction | |
| Brittain et al. | Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertension | |
| Docherty et al. | Heart failure diagnosis in the general community–Who, how and when? A clinical consensus statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) | |
| Omote et al. | Biatrial myopathy in heart failure with preserved ejection fraction | |
| JP7575400B2 (en) | Prescription of biomarker-based remote patient management | |
| Ishiwata et al. | Combined evaluation of right ventricular function using echocardiography in non‐ischaemic dilated cardiomyopathy | |
| Coats et al. | Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial | |
| Guan et al. | Association of left atrial myocardial function with left ventricular diastolic dysfunction in subjects with preserved systolic function: a strain rate imaging study | |
| Laenens et al. | The impact of atrial fibrillation on prognosis in aortic stenosis | |
| Gumus et al. | Assessment of right heart functions in the patients with arteriovenous fistula for hemodialysis access: right ventricular free wall strain and tricuspid regurgitation jet velocity as the predictors of right heart failure |